Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 4,141 | -8,189 | 1,560 | 2,353 | 6,117 |
| Gross Profit | 4,141 | -8,189 | 1,560 | 2,353 | 6,117 |
| Operating Expenses | 21,308 | 23,218 | 16,208 | 17,765 | 15,506 |
| Operating Income | -17,167 | -31,407 | -14,648 | -15,412 | -9,389 |
| Other Income | 656 | 604 | 728 | 748 | 654 |
| Pre-tax Income | -16,511 | -30,803 | -13,920 | -14,664 | -8,735 |
| Income Tax | -102 | -1,629 | 183 | N/A | N/A |
| Net Income Continuous | -16,409 | -29,174 | -14,103 | -13,865 | -8,735 |
| Net Income | $-16,409 | $-29,174 | $-14,103 | $-13,865 | $-8,735 |
| EPS Basic Total Ops | -0.61 | -1.18 | -0.58 | -0.59 | -0.38 |
| EPS Basic Continuous Ops | -0.61 | -1.18 | -0.58 | -0.59 | -0.38 |
| EPS Diluted Total Ops | -0.61 | -1.18 | -0.58 | -0.59 | -0.38 |
| EPS Diluted Continuous Ops | -0.61 | -1.18 | -0.58 | -0.59 | -0.38 |
| EBITDA(a) | $-16,716 | $-30,902 | $-14,153 | $-15,382 | $-9,044 |